Silhouette Instalift

Absorbable Sutures

The first absorbable suture FDA-cleared for cosmetic facial procedures

Absorbable Sutures

The first absorbable suture FDA-cleared for cosmetic facial procedures

Minimal downtime,
long-lasting results.

The procedure only takes under an hour and is done right in your doctor’s office. InstaLift also has minimal downtime with most signs of treatment (ex: bruising, swelling, and tenderness at the treatment site) dissipating within 24–48 hours. Patients can get right back to their activities and enjoy an instant lift in the cheeks, while adding volume over time for long-lasting results.

 

Micro Suspension Technology

Silhouette InstaLift® is a treatment unlike any other. Our Micro Suspension Technology is comprised of micro cones that are placed in the deepest layer of mid-facial skin. It delivers an immediate lift and gradually restores lost facial volume of the mid face by activating your own natural collagen production for a more youthful appearance that continues to improve over time. The sutures and cones are made from poly lactic-co-glycolic acid (PLGA), a well-known biomedical copolymer that is biocompatible and biodegradable.1,2

Results

WHITE PAPER

Expert Consensus on Absorbable Advanced Suspension Technology for Facial Tissue Repositioning and Volume Enhancement and Straight-Line Vector Planning for Optimal Results

B&A 1
Instalift - before image 1

Before

Instalift - after image 1

After

B&A 2
Instalift - before image 2

Before

Instalift - after image 2

After

B&A 3
Instalift - before image 3

Before

Instalift - after image 3

After

B&A 4
Instalift - before image 4

Before

Instalift - after image 4

After

Learn how you can give your practice an instant lift.

IMPORTANT SAFETY CONSIDERATIONS

Silhouette InstaLift is contraindicated in patients with any suspected allergies or foreign body sensitivities to implant orinstrument materials in particular plastic biomaterial and in patients appearing to have very thin soft tissues of the face inwhich the implant may be visible or palpable. The device should not be used in patients with active sepsis or infection, active (or history of) autoimmune disease, patients under 18 years of age, pregnant or breastfeeding women, or patients with limited ability or un-willingness to follow post-treatment recommendations.

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them. Adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction, pain, swelling and edema, transient hematoma or bruising and transient rippling or dimple formation. For more safety information, please consult with your physician and the patient labeling that can be found by visiting www.sunevamedical.com.

Individual technique and results may vary.

Silhouette lnstaLift® is indicated for use in mid-face suspension surgery to temporarily fixate the cheek sub-dermis in an elevated position.

REFERENCES:

  1. Silhouette InstaLift® Instructions for Use. Sinclair Pharmaceuticals; 2019.
  2. Ulery BD, et al. Biomedical applications of biodegradable polymers. J Polym Sci B Polym Phys. 2011; 49(12):832-864.
  3. Nestor MS, et al. Expert consensus on absorbable advanced suspension technology for facial tissue repositioning and volume enhancement. J Drugs Dermatol. 2017; 16(7):661-666.